Kayla Belanger

Kayla Belanger began their work experience in 2018 as an Associate Scientist at bluebird bio, where they worked until 2021. Kayla then joined Revitope in 2021 as a Scientist I before being promoted to Scientist II in 2022. Currently, they are working as a Scientist II at DEM Biopharma, Inc. starting in 2023.

Kayla Belanger completed their education at the University of Rhode Island from 2009 to 2014. During this time, they earned a Bachelor of Science (BS) degree in Chemical Engineering, a Bachelor of Arts (BA) degree in French, and a minor in Biology. Following their undergraduate studies, Kayla enrolled at the Université de Technologie de Compiègne (UTC) from 2014 to 2018. Kayla pursued a Doctor of Philosophy (PhD) degree in Bioengineering at UTC.